Table II.
Univariate and multivariate analysis for outcomes
Variables |
Univariate |
Model 1 |
Model 2 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Multivariate |
Multivariate |
|||||||||
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | ||
Outcome: mortality | ||||||||||
HA-COVID-19 | 0.99 | 0.53–1.81 | 0.966 | 0.78 | 0.41–1.47 | 0.438 | 0.80 | 0.42–1.52 | 0.498 | |
CCI ≥5 | 3.59 | 2.56–5.0 | <0.001 | 3.69 | 2.62–5.2 | <0.001 | ||||
Male | 1.84 | 1.31–2.59 | <0.001 | 1.87 | 1.31–2.67 | <0.001 | 2.03 | 1.42–2.91 | <0.001 | |
>65 years | 3.48 | 2.45–4.9 | <0.001 | 3.29 | 2.28–4.73 | <0.001 | ||||
CKD | 2.35 | 1.63–3.40 | <0.001 | 1.80 | 1.22–2.67 | 0.003 | ||||
Outcome: discharged within 30 days | ||||||||||
HA-COVID-19 | 0.41 | 0.24–0.72 | 0.011 | 0.44 | 0.25–0.78 | 0.005 | 0.44 | 0.25–0.78 | 0.005 | |
CCI≥5 | 0.47 | 0.35–0.63 | <0.001 | 0.50 | 0.37–0.67 | <0.001 | ||||
Male | 0.59 | 0.43–0.79 | <0.001 | 0.57 | 0.41–0.77 | <0.001 | 0.56 | 0.41–0.76 | <0.001 | |
>65 years | 0.53 | 0.40–0.71 | <0.001 | 0.60 | 0.43–0.81 | <0.001 | ||||
CKD | 0.54 | 0.38–0.77 | <0.001 | 0.68 | 0.47–1.00 | 0.048 | ||||
Diabetes | 0.55 | 0.39–0.78 | <0.001 | 0.68 | 0.48–0.98 | 0.036 | ||||
Outcome: ICU admission | ||||||||||
HA-COVID-19 | 0.6 | 0.32–1.14 | 0.116 | 0.76 | 0.39–1.46 | 0.409 | 0.78 | 0.40–1.51 | 0.461 | |
CCI ≥5 | 0.4 | 0.31–0.61 | <0.001 | 0.43 | 0.31–0.60 | <0.001 | ||||
Male | 2.1 | 1.48–2.84 | <0.001 | 2.13 | 1.53–3.00 | <0.001 | 2.05 | 1.47–2.85 | <0.001 | |
>65 years | 0.4 | 0.26–0.50 | <0.001 | 0.40 | 0.28–0.55 | <0.001 | ||||
CKD | 0.4 | 0.29–0.68 | <0.001 | 0.59 | 0.38–0.92 | 0.021 |
CCI, Charlson Comorbidity Index; CI, confidence interval; CKD, chronic kidney disease; HA-COVID-19, healthcare-associated COVID-19; ICU, intensive care unit; OR, odds ratio.